No Kings! Americus · No Kings **We have the power and are claiming it together. No Thrones. No Crowns. No Kings.** What began in 2025 as a single day of defiance has become a sustained national resistance to tyranny, spreading fr...

Come join us in Americus at 1pm as we take part in the largest peaceful protest in American history- happening all around the world tomorrow 🩵🔥 mobilize.us/s/iPTWfc
#nokings3ga #nokings3 #indivisible #igc #southgaprotest #indivisiblegeorgiacoalition

UK companies in the news:

#CABP #CRN #EML #IGC #IPF #JDW #NSI #OGN #POW #SEIT #SMIN #SML #SOU #TMIP #TMPL #ULVR #WRKS #ZEN

Head to Sharesify.com for news, views and analysis.

IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 IGC Pharma (NYSE:IGC)/b) filed its Form 10-KT on March 19, 2026 for the nine months ended , reflecting a fiscal year change to December year-end.Key points: Phase 2 CALMA enrollment surpassed 70%; net loss improved by $1.8M to $4.1M; $2.7M divestiture yielded ~$1.1M non-cash profit; R&D rose 48% to $4.0M; revenue was $869k. The company highlighted U.S. patents for IGC-AD1 formulation and a microdose cannabinoid, positive preclinical in-vitro data, AI awards, and plans to complete CALMA enrollment and pursue partnerships and AI monetization in FYE 2026.

#IGC IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025

www.stocktitan.net/news/IGC/igc-pharma-repo...

IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 IGC Pharma (NYSE:IGC) will demonstrate its Agentic Harmonization Assistant (AHA), an AI platform for automating harmonization and analysis of complex biomedical datasets, at ADPD 2026 in collaboration with the Alzheimer's Disease Data Initiative (ADDI).AHA targets integration of clinical trial data, imaging, and other biomedical sources to reduce manual preparation time and support development of IGC-AD1 in the Phase 2 CALMA trial.

#IGC IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026

www.stocktitan.net/news/IGC/igc-pharma-to-s...

🎙️ Deputy Minister for European Affairs Marilena Raouna at today’s #IGC 🇲🇪.

Read the main results here 👉 link.berry.social/main-results/IGC-Montenegro/17.03.2026

The Business of Horticulture Course - UCLA Extension An introduction to starting, developing and growing a horticulture business.

Dream of starting or revitalizing a #Horticulture or allied trade biz? Join my “The Business of Horticulture” course through @uclaextension.bsky.social
Online, 6-weeks, asynchronous, weekly office hours w/me www.uclaextension.edu/landscape-ar...
#IGC #Plantrepreneur #GreenIndustry #Business.

We are excited to announce that the first Call for Abstracts for the IGC 2027 is now open!

The International #Grassland Congress will take place in Leipzig, Germany from June 13–18, 2027. Hosted by #ZALF, the JKI, and the #Thünen Institute, the #IGC invites the global community to submit abstracts under the theme "100 Years of Grassland Research — Ways to the Future".
igc2027.org
#IGC2027

IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research IGC Pharma (NYSE:IGC) announced on February 26, 2026 that it filed utility patent applications covering the architectural framework of its AI-based Agentic Harmonization Assistant (AHA). IGC says AHA standardizes heterogeneous Alzheimer's datasets; the company has harmonized 15 datasets and advanced AHA to a semi-final AI evaluation.The filings aim to protect AHA's design and methodologies while IGC continues CALMA clinical trial work and plans additional AHA details at the upcoming ADPD conference.

#IGC IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research

www.stocktitan.net/news/IGC/igc-pharma-file...

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship Network Site, in Richmond, Virginia IGC Pharma (NYSE:IGC) added Dominion Medical Associates, a Lightship network site in Richmond, Virginia, to its Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer's disease on January 12, 2026. The site will use Lightship's hybrid access model combining in-clinic, remote, and in-home visits supported by mobile research nurses and validated technology to expand access, reduce participant burden, improve retention, and accelerate enrollment across underserved and rural communities. IGC-AD1 is a cannabinoid-based investigational therapy being studied in a randomized, double-blind, placebo-controlled Phase 2 trial. The expansion aims to strengthen trial execution, participant diversity, and timely study completion while maintaining investigator oversight, protocol adherence, and data integrity.

#IGC IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship Network Site, in Richmond, Virginia

www.stocktitan.net/news/IGC/igc-pharma-expa...

İGC Başkanı Gappi’den iktidara ve yerel yönetimlere sert mesaj: Yerel medya hançerleniyor! - Demokrat Gündem - Haberler - Son Dakika Haberleri İGC Başkanı Dilek Gappi, CHP’nin İzmir’de düzenlediği Yerel Medya Buluşması’nda gazetecilik mesleğinin dijital çağdaki krizini masaya yatırdı.

Gazetecilik 5N1K değil, '5N1M' (Menfaat) oldu!

İGC Başkanı Gappi, 10 Ocak'ta acı tabloyu çizdi:

"Yerel medya arkadan hançerleniyor. Ama biz fikri isyanımızı kalemimizle sürdüreceğiz."

demokratgundem.com/igc-baskani-...

#izmir #igc #dilekgappi #izmirgazetecilercemiyeti

IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum IGC Pharma (NYSE American: IGC) announced that the USPTO issued U.S. Patent No. 12,491,200 on December 19, 2025, covering a novel microdose-based cannabinoid treatment for stuttering and Tourette's Syndrome.The patent protects ultra-low THC dosing, alone or with CBD or other agents, to modulate neural circuits tied to vocal disruptions and tics, and complements IGC's existing neurological pipeline including IGC-AD1 in the CALMA trial for agitation in Alzheimer's disease.

#IGC IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum

www.stocktitan.net/news/IGC/igc-pharma-secu...

第6回IGC開催レポートと次回スポンサーの募集について 2025年11月に第6回IGCが開催されました。高評価の裾野を広げるべく、次回イベントのスポンサー企業を募集します。

第6回IGC開催レポートと次回スポンサーの募集について #東京都 #渋谷区 #ログミー株式会社 #IGC #三浦由加里

2025年11月に第6回IGCが開催されました。高評価の裾野を広げるべく、次回イベントのスポンサー企業を募集します。

IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines IGC Pharma (NYSE American: IGC) commented on recent federal momentum toward possible Schedule III reclassification for cannabinoids and positioned itself as a focused beneficiary within the FDA-regulated pharmaceutical pathway. The company highlighted its lead candidate, IGC-AD1, currently in a Phase 2 CALMA study for agitation associated with Alzheimer’s disease, and emphasized a long‑horizon strategy built on microdosing, safety, patents, and AI-driven drug development.IGC outlined potential long-term benefits if policy evolves, including expanded clinical institution participation, more efficient pharma-grade manufacturing and supply chains, and improved engagement from financial institutions and capital markets.

#IGC IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines

www.stocktitan.net/news/IGC/igc-pharma-posi...

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial IGC Pharma (NYSE:IGC) announced it has reached 65% patient enrollment in the Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer’s disease as of December 9, 2025. The company said enrollment has accelerated and remains on track for trial completion in early 2026. The release notes a hybrid recruitment approach: 25% of participants were recruited via targeted social-media campaigns and 75% via clinical sites. Interim analyses previously reported by the company showed clinical and statistically significant reductions in agitation. IGC continues to expand U.S. and Canada clinical operations and to focus on data quality and site performance.

#IGC IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial

www.stocktitan.net/news/IGC/igc-pharma-repo...

الدكتور خالد العناني في نيودلهي: اليونسكو تبرز التراث الثقافي غير المادي في القلعة الحمراء استكشف جهود الدكتور خالد العناني في نيودلهي لحماية التراث الإنساني وتفاصيل جديدة عن برامجه التفاصيل عبر موقعنا بلاك كات 24.

India unites the world at the Red Fort! 🇮🇳 Dr. Khaled El-Enany 🇪🇬 inaugurated the 20th UNESCO ICH Committee session in New Delhi, championing the safeguarding of our shared living heritage. ✨ #DrKhaledElEnany #20COM2025 #UNESCO #ICH #IGC

#IGC IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease

www.stocktitan.net/news/IGC/igc-pharma-anno...

IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends IGC Pharma (NYSE American: IGC) announced advances in MINT-AD, a Multimodal Interpretable Transformer for Alzheimer’s that uses AI and global longitudinal datasets to identify socioeconomic risk factors tied to cognitive decline. The model was trained on 14 large-scale HRS-based studies spanning the USA, Africa, Mexico, China, Costa Rica, Puerto Rico, Chile, Brazil, England, Thailand, Indonesia, India, and Korea. The initiative targets risk stratification, early detection, and simulation of disease progression under interventions, and complements ongoing IGC-AD1 clinical trials aimed at agitation and potential disease-modifying therapies.IGC says the work may enable earlier prediction, personalized non-pharmacological interventions, and data-driven public health strategies.

#IGC IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends

www.stocktitan.net/news/IGC/igc-pharma-leve...

Are you in the Americus GA area today and sick of Neo Nazi ideology sucking your neighbors into a hate-fueled rabbit hole!? Come protest the Turning Point action meeting at 5:45pm outside of The Spot bar! #protestswga #boycottthespot #indivisibleGA #nokings #nofascists #protectourcommunity #igc

#IGC USPTO Grants IGC Pharma Patent Covering IGC-AD1 for Novel Composition Targeting Alzheimer's Disease and Central Nervous System Disorders

www.stocktitan.net/news/IGC/uspto-grants-ig...

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline IGC Pharma (NYSE:IGC) announced an expansion of its AI-powered in-silico drug discovery platform on November 3, 2025, adding retrosynthetic analysis, molecular docking, toxicology/genotoxic assessment, and predictive bioactivity modeling.The upgrade aims to accelerate identification and optimization of Alzheimer's candidates by prioritizing compounds in its patent portfolio, predicting target interactions, and flagging toxicity earlier to reduce experimental burden. Ongoing programs noted include IGC-AD1 (Phase 2), TGR-63 (preclinical plaque clearance in cortex and hippocampus), IGC-1C (tau/GLP-1 dual action), and IGC-1A (AI-identified GLP-1 agonist).

#IGC IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

www.stocktitan.net/news/IGC/igc-pharma-expa...

CALL NOW: TELL DEMOCRATIC SENATORS TO KEEP HOLDING THE LINE IN THE SHUTDOWN FIGHT

In GA and want to take some meaningful action?
indivisible.org/resource/cal...
#senatedems #contactwarnock #contactossoff #igc #indivisible
#fightforhealthcare

Congratulations to Clare Balboni #STICERD #EEE #LSEEconomics #IGC who has been awarded a Philip Leverhulme Prize 2025 @leverhulme.ac.uk to fund research at the intersection of environmental economics, trade and development economics.
sticerd.lse.ac.uk/_new/News/ab...

Rentrée solennelle de l'institut Georges Chappaz : une belle réussite pour cette seconde édition. Une conférence de S Couvreur très intéressante sur le label UNESCO donné à la Champagne, devant un amphi plein d'étudiants et de personnels.
@universitereims.bsky.social
#igc, @unesco.org, #SCouvreur

IGC Eleva Previsão de Safra de Trigo para 827 Milhões de Toneladas Forbes, a mais conceituada revista de negócios e economia do mundo. O Conselho Internacional de Grãos elevou sua previsão em 8 milhões de toneladas O post IGC Eleva Previsão de Safra de Trigo para 827 Milhões de Toneladas apareceu primeiro em Forbes Brasil.

IGC Eleva Previsão de Safra de Trigo para 827 Milhões de Toneladas Forbes, a mais conceituada revista de negócios e economia do mundo. O Conselho Internacional de Grãos elevou sua previsão em 8 milhões de toneladas O post IGC Eleva Previsão de Safra de Trigo para 827 Milhões de Toneladas apareceu primeiro em Forbes Brasil.

IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant" IGC Pharma (NYSE American: IGC) announced that its project "AHA: Agentic Harmonization Assistant" was selected as a semi-finalist in the $1 million Alzheimer's Insights AI Prize organized by the Alzheimer's Disease Data Initiative. The company said AHA builds on its MINT-AD deep-learning platform, which integrates clinical, neuroimaging, genetic, lifestyle, cognitive, and genomic data to address data harmonization in Alzheimer’s drug discovery.The semi-final presentation is scheduled for December 5, 2025 in San Diego, following the CTAD conference. IGC framed the selection as recognition of its AI-driven research capabilities and team execution.

#IGC IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant"

www.stocktitan.net/news/IGC/igc-pharma-adva...

So incredibly proud of #nokingsamericus and everyone who helped make it happen! We had around 85 people in attendance as we joyfully celebrated resistance together!
Our next meeting is 11/01/25 at 1pm in the back room of Cafe Campesino! #indivisible #IGC #activism #swga #americusga #nokingsday

Science, Stories and Stone: My Research Journey in Edinburgh – Institute of Genetics and Cancer A blog for our community to write about their interests and to share their stories.

"...research isn’t just about data and discoveries; it’s about people, perspectives, and the places that inspire us."
@sunandan.bsky.social from @iimcb.bsky.social has written about his experience of visiting Edinburgh and #IGC for a two-week research visit 👉

IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences POTOMAC, MD, 1734 / ACCESS Newswire / October 14, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced the expansion of its ongoing Phase 2

#IGC IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences

www.stocktitan.net/news/IGC/igc-pharma-expa...

NO KINGS Americus! · No Kings **In America, we don’t put up with would-be kings.** Our peaceful movement is only getting bigger and stronger. “NO KINGS” is more than just a slogan—it’s the foundation our nation was built upon. Bo...

In the SWGA area and looking for a way to channel all the "WTF" or "OMFG" you might be feeling lately? Sat. October 18th, at 9:30AM in Americus Ga is where to be! Join us for the largest, nation-wide protest in US history! www.mobilize.us/nokings/even... #indivisible #nokingsday #swga #nkdga #igc